Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The most clinically relevant efficacy data came from METAOD005, a 12-week randomized double-blind placebo-controlled study
the mouse study used dosing three times daily
Close post treatment follow-up to attend to any concerns, review results & ensure patient satisfaction
Contraindications and Precautions: AOD-9604 should be avoided or used only under close medical supervision in individuals with active malignancy or history of cancer, as the effects of the peptide on tumor growth have not been adequately studied
Synthetic Lipolytic Domain Characterization Ng et al., Hormone Research (2000) Ng and colleagues conducted foundational characterization studies of the AOD-9604 synthetic lipolytic domain using a combination of in vitro adipocyte assays and in vivo obese Zucker rat models
doi:10.3390/nano11030743
US$ 25.27
US$ 23.73
US$ 20.01
US$ 22.90
US$ 23.50
US$ 26.17
US$ 28.17
US$ 28.12
US$ 29.30